These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome. Slocum MM; Adams JG; Teel R; Spadone DP; Silver D J Vasc Surg; 1996 May; 23(5):839-43. PubMed ID: 8667505 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy. Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530 [TBL] [Abstract][Full Text] [Related]
9. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator. Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775 [TBL] [Abstract][Full Text] [Related]
10. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls. Burgess JK; Chong BH Eur J Haematol; 1997 Apr; 58(4):279-85. PubMed ID: 9186540 [TBL] [Abstract][Full Text] [Related]
11. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery]. Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025 [TBL] [Abstract][Full Text] [Related]
12. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Kikta MJ; Keller MP; Humphrey PW; Silver D Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of platelet function using stagnation point flow aggregometry. First clinical results. Reininger CB; Reininger AJ; Hörmann A; Steckmeier B; Schweiberer L Int Angiol; 1992; 11(4):247-55. PubMed ID: 1295930 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban. Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088 [TBL] [Abstract][Full Text] [Related]
17. A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery. Lindhoff-Last E; Eichler P; Stein M; Plagemann J; Gerdsen F; Wagner R; Ehrly AM; Bauersachs R Thromb Res; 2000 Mar; 97(6):387-93. PubMed ID: 10704647 [TBL] [Abstract][Full Text] [Related]
18. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Morris TA; Castrejon S; Devendra G; Gamst AC Chest; 2007 Oct; 132(4):1131-9. PubMed ID: 17646239 [TBL] [Abstract][Full Text] [Related]
19. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Greinacher A; Amiral J; Dummel V; Vissac A; Kiefel V; Mueller-Eckhardt C Transfusion; 1994 May; 34(5):381-5. PubMed ID: 8191560 [TBL] [Abstract][Full Text] [Related]
20. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Wakeling A; Dandona P Eur J Clin Invest; 1985 Dec; 15(6):313-9. PubMed ID: 3938401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]